J.ReÂtey et al.
FULL PAPER
l-phenylalanine: 41.7 min, 2'-fluoro-l-phenylalanine: 42.4 min, 3'-fluoro-l-
phenylalanine: 44.1 min, 4'-fluoro-l-phenylalanine: 43.9 min, 2',6'-di-
fluoro-l-phenylalanine: 42.7 min, 3',5'-difluoro-l-phenylalanine: 46.5 min,
arise by rotation of the substrate prior to the active complex formation,
model A represents the structure where the halogen substituent is closer to
the sp center in the s complex.
3
2
',3',4',5',6'-pentafluoro-l-phenylalanine: 48.4 min, 2'-chloro-l-phenylala-
The putative active site model was built from a sequence segment of PAL
nine: 45.3 min, 3'-chloro-l-phenylalanine: 48.0 min, 4'-chloro-l-phenylala-
nine: 48.7 min]. For the determination of the enantiomeric excess we used a
chiral column from astec/ict (Handels-GmbH, 61352 Bad Homburg,
(
SP: P24481) containing the ASGDL active site motif and the F399 by
[27]
[10]
homology-modelling using HAL structure (PDB: 1B8F ) as folding
template, followed by Gromos and Amber energy minimizations.The
ASG structure of the model was finally replaced by MIO taken from the
[27]
[26]
Germany) (Chirobiotic T, 5 mm, 250 Â 4.6 mm; mobile phase: 70% H
2
O/
À1
3
0% EtOH; flow rate: 0.8 mLmin ; load: 5 mg; retention times: l-
1
B8F HAL structure (less than 0.4 deviations in the corresponding
phenylalanine: 7.22 min, 2'-fluoro-l-phenylalanine: 6.87 min, 3'-fluoro-l-
phenylalanine: 6.98 min, 4'-fluoro-l-phenylalanine: 7.20 min, 2',6'-difluoro-
l-phenylalanine: 6.42 min, 3',5'-difluoro-l-phenylalanine: 6.75 min,
atomic positions).
Partial active site/s complex models (c.f. Scheme 1) were obtained using
MM optimization (with fixed position of the methyl groups of the MIO
2
',3',4',5',6'-pentafluoro-l-phenylalanine: 5.89 min, 2'-chloro-l-phenylala-
[
26]
and Phe399 models and carboxylate of the substrate) followed by single
point PM3 calculation of the optimized structure.[
nine: 9.06 min, 3'-chloro-l-phenylalanine: 8.22 min, 4'-chloro-l-phenylala-
nine: 9.25 min). In all cases enantiomeric excess over 99% was determined.
The d-enantiomers were eluted between 1 and 2 min later, as described in
the astec/ict prospect.
25]
Acknowledgements
b-(2-Pyrimidinyl)-d,l-alanine (1): Preparation as reported by W.J.Hagg-
[
22]
erty, R.H.Springer, and C.C.Cheng.
We thank M.Baedeker and G.Schulz (Universität Freiburg) for the
improved expression system for PAL .Financial support by the Deutsche
Forschungsgemeinschaft, the Fonds der Chemischen Industrie, the Hun-
garian OMFB and the Polish Science Foundation Council through the
Wroclaw University of Technology Fund is gratefully acknowledged.
b-(5-Pyrimidinyl)-l-alanine (2): b-(5-Pyrimidinyl)-acrylic acid (3) obtained
by Heck coupling between 5-bromopyrimidine and tert-butyl acrylate,
followed by ester-cleavage in TFA.[
[23]
24]
A concentrated, aqueous ammonia-solution (10 mL) was diluted with
distilled water (10 mL).The pH was adjusted to 10 0. by bubbling CO
2
into
the solution.Acrylic acid 3 (64.3 mg, 0.428 mmol) and PAL (1 U) were
added to this solution.After 24 h agitation at 37 8C the enzyme was
denatured by heat and removed by filtration.The clear solution was
applied to a Dowex 50 cation exchange resin column.The elution occurred
with diluted ammonia solution.The crude product was purified with HPLC
[
[
1] K.R.Hanson, E.A H. avir, Recent Adv. Phytochem. 1978, 12, 91 ± 137.
2] K.Hahlbrock, D.Scheel, Annu. Rev. Plant Physiol. Plant Mol. Biol.
1
989, 40, 347 ± 369.
[
[
[
[
[
3] K.R.Hanson, E.A.Havir, Arch. Biochem. Biophys. 1970, 141, 1 ± 77.
4] K.R.Hanson, E.A.Havir, Biochemistry 1973, 12, 1583 ± 1591.
5] E.A.Havir, P.D.Reid, H.V.March, Plant Physiol. 1971, 48, 130 ± 136.
6] B.Schuster, J.Re Âtey, FEBS Lett. 1994, 349, 252 ± 254.
(
5
1
Nucleosil 100 C18, 7 mm, 250 Â 20 mm; Macherey ± Nagel, flow rate:
À1
mLmin ; load: 20 mg; mobile phase: 0 ± 15 min: 99.9% H
2
O/0.1% TFA,
3
5 ± 90 min: linear increasing gradient to 99.9% CH CN/0.1% TFA,
7] M.Langer, G.Reck, J.Reed, J.Re Âtey, Biochemistry 1994, 33, 6462 ±
retention times: 23.5 min). The solvent was carefully removed under
reduced pressure to give a white solid (50 mg, 0.246 mmol, 57%).
6
467.
[
[
8] K.R.Hanson, E.A.Havir, Biochem. Plants 1981, 7, 577 ± 625.
9] W.Schulz, H.G.Eiben, K.Hahlbrock, FEBS Lett. 1989, 258, 335 ± 338.
Determination of Vmax- and K
m
values: The kinetic constants were
determined by measuring the UV absorption of the produced
[
10] T .F .Schwede, J.Re Âtey, G.E. Schulz, Biochemistry 1999, 38, 5355 ±
361.
11] M.Ormö, A B. .Cubitt, K.Kallio, L A. .Gross, R Y. .Tsien, S J. .
Remington, Science 1996, 273, 1392 ± 1395.
12] K.J.Luebke, Chem. Biol. 1998, 5, 317 ± 322.
13] G.J.Palm, A.Zdanov, G.A.Gaitanaris, R.Stauber, G.N.Pavlakis, A.
Wlodawer, Nat. Struct. Biol. 1997, 4, 361 ± 365.
À1
À1
acrylates (trans-cinnamic acid: e290 10000 Lcm mol ; 2'-fluorocinnamic
5
À1
À1
acid:
e
280 12550 Lcm mol
;
3'-fluorocinnamic
acid:
e
280
À1
[
À1
À1
À1
1
3850 Lcm mol
;
4'-fluorocinnamic acid:
e
À1
280 15320 Lcm mol
;
À1
2
',6'-difluorocinnamic acid: e290 3960 Lcm mol ; 3',5'-difluorocinnamic
[
[
À1
À1
acid: e290 5060 Lcm mol ; 2',3',4',5',6'-pentafluorocinnamic acid: e280
À1
À1
À1
À1
7
910 Lcm mol
;
2'-chlorocinnamic acid:
e
285 10770 Lcm mol
;
À1
À1
3
'-chlorocinnamic acid:
e
285 10680 Lcm mol
290 15790 Lcm mol
1110 Lcm mol ) using 0.05 ± 10mm of the corresponding amino acid
;
4'-chlorocinnamic
[
14] T .A .Smith, F .H .Cordelle, R .H .Abeles,
Arch. Biochem. Biophys.
À1
À1
acid:
1
e
;
b-(5-pyrimidinyl)-acrylic acid:
e
270
1
967, 120, 724 ± 725.
À1
À1
[
[
[
[
15] B.Schuster, J.ReÂtey, Proc. Natl. Acad. Sci. USA 1995, 92, 8433 ± 8437.
16] J.ReÂtey, Naturwissenschaften 1996, 83, 439 ± 447.
17] A.Peterkofsky, J. Biol. Chem. 1962, 237, 787 ± 795.
18] M.Yanaka, U.Ura, A.Takahashi, N.Fukuhara, Mitsui Toatsu
Chemicals, Jpn.Kokai Tokyo Koho JP06, 113870 [94113870]
Cl.C12P13/06), 1994 [Chem. Abstr. 1994, 121, 155941].
19] J.D. Hermes, P.M. Weiss, W.W. Cleland, Biochemistry 1985, 24,
959 ± 2967.
20] A.Gloge, B.Langer, L.Poppe, J.Re Âtey, Arch. Biochem. Biophys.
998, 359, 1 ± 7.
as substrate.Conditions: 0 0. 5m m ± 10mm substrate in 0.1m Tris-HCl buffer
pH 8.8 at 308C.The reaction was initiated by addition of 20 mg (0.02 U)
1
PAL. H-NMR (250 MHz; D
5
2
O, 25 8C): l-phenylalanine: d 7.28 ± 7.43 (m,
H), 3.96 (t, 1H), 3.27 (dd, 1H), 3.08 (dd, 1H), 2'-fluoro-l-phenylalanine:
d 7.34 (m, 2H), 7.17 (m, 2H), 4.26 (t, 1H), 3.40 (dd, 1H), 3.20 (dd, 1H), 3'-
(
fluoro-l-phenylalanine: d 7.38 (m, 1H), 7.08 (m, 3H), 4.19 (t, 1H), 3.32
[
[
[
[
(
(
dd, 1H), 3.16 (dd, 1H), 4'-fluoro-l-phenylalanine: d 7.26 (m, 2H), 7.10
m, 2H), 4.28 (t, 1H), 3.29 (dd, 1H), 3.15 (dd, 1H), 2',6'-difluoro-l-
2
phenylalanine: d 7.36 (m, 1H), 6.99 (m, 2H), 4.28 (t, 1H), 3.37 (dd, 1H),
1
3
1
.26 (dd, 1H), 3',5'-difluoro-l-phenylalanine: d 6.90 (m, 3H), 4.32 (t,
21] A.Lewandowicz, J.Jemielity, M.Kan Âska, J.ZonÂ, P.Paneth, Arch.
H), 3.35 (dd, 1H), 3.17 (dd, 1H), 2',3',4',5',6'-pentafluoro-l-phenylala-
Biochem. Biophys. 1999, 370, 216 ± 221.
nine: d 4.01 (t, 1H), 3.26 (dd, 1H), 3.19 (dd, 1H), 2'-chloro-l-phenyl-
22] W.J. Haggerty, R.H. Springer, C.C. Cheng,
964, 2, 1 ± 6.
23] M.Baedeker, G.E.Schulz, FEBS Lett. 1999, 457, 57 ± 60.
24] J.E. Plevyak, J.E. Dickerson, R.F. Heck, J. Org. Chem. 1979, 44,
078 ± 4080.
[25] PC Spartan Pro, Wavefunction, Inc., 18401 Von Karman, Suite 370,
Irvine, CA 92612, USA.
[26] HyperChem 5.1, Hypercube, Inc., 1115 NW 4th Street, Gainesville,
32601, FL, USA.
J. Heterocycl. Chem.
alanine: d 7.48 (m, 1H), 7.34 (m, 3H), 4.05 (t, 1H), 3.45 (dd, 1H), 3.16 (dd,
1
1
1
2
H), 3'-chloro-l-phenylalanine: d 7.36 (m, 3H), 7.21 (m, 1H), 4.20 (t,
H), 3.31 (dd, 1H), 3.16 (dd, 1H), 4'-chloro-l-phenylalanine: d 7.40 (d,
H), 7.26 (d, 2H), 3.97 (t, 1H), 3.23 (dd, 1H), 3.10 (dd, 1H).
[
[
4
Theoretical calculations
Simple s-complex models for l-phenylalanine, the halogenated l-phenyl-
alanine, and pyrimidinyl-l-Ala derivatives were calculated in vacuo using
[
25, 26]
AM1 and PM3 methods.
Conformational analysis showed two favored
states for zwitterionic structures with antiperiplanar pro-S H
b
ÀNH
3
and
[27] Swiss-PdbViewer, 3 5. 1, N.Guex, M.C.Peitsch,
Electrophoresis 1997,
zig ± zag arrangement (Scheme 3).All further calculations refer to the
arrangement with a fixed F À908 torsion angle.Since the parallel results
from the two methods were similar, values derived from PM3 calculations
are indicated only.In the cases where two distinct s complex models may
18, 2714 ± 2723.
Received: October 18, 1999
Revised version: March 3, 2000 [F2095]
3390
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2000
0947-6539/00/0618-3390 $ 17.50+.50/0
Chem. Eur. J. 2000, 6, No. 18